<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhou Y</submitter><funding>Natural Science Foundation of Zhejiang Province</funding><funding>Youth Cultivation Plan 'Cultivation Star Project' of Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital</funding><funding>National Natural Science Foundation of China</funding><funding>Zhejiang Provincial Science and Technology Innovation Program</funding><funding>Zhejiang Provincial Science and Technology Innovation Program (New Young Talent Program) for College Students</funding><funding>Characteristic Directional S-Disciplines of The First Affiliated Hospital of Wenzhou Medical University</funding><funding>Science and Technology Project of Wenzhou</funding><funding>Health Commission of Zhejiang Province</funding><pagination>e70621</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12940804</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Ageing is a significant risk factor for pathophysiological alterations in the heart, but the intrinsic mechanisms by which these occur have yet to be fully elucidated. Purinergic 2×7 receptor (P2X7R) is important for the pathogenesis of numerous cardiovascular diseases; nevertheless, its function in the process of cardiac ageing remains uncertain.&lt;h4>Methods&lt;/h4>This study utilised P2X7R knockout (P2X7R&lt;sup>-&lt;/sup>/&lt;sup>-&lt;/sup>) mice. An ageing model was established by either maintaining mice until they reached 20 months of age or performing chronic subcutaneous injection of D-galactose (D-gal). Recombinant adeno-associated virus serotype 9 (AAV9) was employed to achieve cardiac-specific overexpression of P2X7R and nuclear receptor subfamily 4 group A member 1 (NR4A1). C</pubmed_abstract><journal>Clinical and translational medicine</journal><pubmed_title>P2X7R deficiency alleviates cardiac senescence by enhancing mitophagy via the HuR/TRIM26/NR4A1 axis.</pubmed_title><pmcid>PMC12940804</pmcid><funding_grant_id>2024R413C089</funding_grant_id><funding_grant_id>80225018</funding_grant_id><funding_grant_id>ZCLMS26H0201</funding_grant_id><funding_grant_id>wyyy-2025S02</funding_grant_id><funding_grant_id>82570459</funding_grant_id><funding_grant_id>Y20240070</funding_grant_id><funding_grant_id>82202380</funding_grant_id><funding_grant_id>WKJ-ZJ-2540</funding_grant_id><funding_grant_id>2024PY192</funding_grant_id><funding_grant_id>Y2023127</funding_grant_id><pubmed_authors>Shen J</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Ye B</pubmed_authors><pubmed_authors>Zhong X</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Xing J</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Huang Z</pubmed_authors><pubmed_authors>Mei J</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Lin J</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Mao Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>P2X7R deficiency alleviates cardiac senescence by enhancing mitophagy via the HuR/TRIM26/NR4A1 axis.</name><description>&lt;h4>Background&lt;/h4>Ageing is a significant risk factor for pathophysiological alterations in the heart, but the intrinsic mechanisms by which these occur have yet to be fully elucidated. Purinergic 2×7 receptor (P2X7R) is important for the pathogenesis of numerous cardiovascular diseases; nevertheless, its function in the process of cardiac ageing remains uncertain.&lt;h4>Methods&lt;/h4>This study utilised P2X7R knockout (P2X7R&lt;sup>-&lt;/sup>/&lt;sup>-&lt;/sup>) mice. An ageing model was established by either maintaining mice until they reached 20 months of age or performing chronic subcutaneous injection of D-galactose (D-gal). Recombinant adeno-associated virus serotype 9 (AAV9) was employed to achieve cardiac-specific overexpression of P2X7R and nuclear receptor subfamily 4 group A member 1 (NR4A1). C</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Mar</publication><modification>2026-07-16T21:55:48.395Z</modification><creation>2026-07-10T03:16:26.906Z</creation></dates><accession>S-EPMC12940804</accession><cross_references><pubmed>41746668</pubmed><doi>10.1002/ctm2.70621</doi></cross_references></HashMap>